Photo
May 18, 2018
Kite Pharma drug Yescarta passed a clinical trial milestone.
Stories this photo appears in:
Kite Partners to Develop Leukemia Treatments
Santa Monica pharmaceutical concern Kite is partnering with HiFiBiO Inc. to develop therapies to treat acute myeloid leukemia.
Kite Cancer Drug Passes a Key Test
Company seeks approval to expand use of Yescarta
Santa Monica pharmaceutical concern Kite Pharma has passed a key clinical trial milestone as it seeks to expand the use of one of its breakthrough drugs to treat a form of non-Hodgkin’s lymphoma cancer.
Kite Adds Production in Europe
HEALTH CARE: Santa Monica-based biopharma to manufacture in Netherlands
The Santa Monica-based Kite pharmaceutical operation has leased a building in the Netherlands to produce its gene-based cancer therapies in Europe, the company announced last week.